Jason Wright, DPM
Podiatrist · Chelsea, MINPI 1306330261
Payments from drug & device makers
What this record shows
This record is dominated by education: $6,901 of the $9,080 with a category attached, or 76.0%. Pinnacle, Inc accounts for 76.8% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2020 at $5,028 and has fallen 90.5% since, to $476 in 2025. Among podiatrist clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 63 payments — averaging $144.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pinnacle, Inc$7K
- Kerecis Limited$352
- Stryker$307
- Treace Medical Concepts, Inc.$294
- Smith+Nephew$192
- Organogenesis Inc.$125
- plus $840 from 12 others
What the payments were for
- Travel & lodging$220%
- Food & beverage$2,15724%
- Education$6,90176%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pinnacle, Inc | 9 | $6,970 |
| Kerecis Limited | 8 | $352 |
| Stryker | 15 | $307 |
| Treace Medical Concepts, Inc. | 6 | $294 |
| Smith+Nephew | 7 | $192 |
| Organogenesis Inc. | 1 | $125 |
| Amgen | 1 | $123 |
| Misonix Inc | 1 | $120 |
| AbbVie | 2 | $111 |
| Paragon 28, Inc. | 3 | $107 |
| Acell, Inc. | 1 | $101 |
| Osteomed LLC | 1 | $99 |
| Johnson & Johnson | 2 | $81 |
| Integra Lifesciences Corporation | 2 | $36 |
| Merz North America, Inc. | 1 | $20 |
| Solventum Corporation | 1 | $18 |
| Nevro Corp. | 1 | $15 |
| Medela LLC | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,080 in reported general payments places this provider in the 90th percentile of 302 podiatrist providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 26 | $569 |
| Gabapentin | 27 | $284 |
| CiclopiroxCiclopirox Olamine | 17 | $283 |
| Cephalexin | 47 | $184 |
| Terbinafine Hcl | 13 | $164 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 16 | $103 |
| Meloxicam | 27 | $53 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 17 | $42 |
| Tramadol Hcl | 12 | $10 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Chelsea
- Shana ShettyChelsea$9K
- Fadi JaafarAlma$191K
- Jeffrey KleinLivonia$117K
- Gary RothenbergAnn Arbor$85K
- Randy SemmaCommerce Twp$31K
- Alton JohnsonAnn Arbor$21K
- Krista KotzevaSouthfield$20K
- Darryl MartinsJackson$19K
- Hassan AlkhalilDearborn$18K
- Joshua KazdanSouthfield$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.